Novartis Shares Rise After Full-Year Guidance Confirmed
- ByInvesting.com-
By Scott Kanowsky Investing.com -- U.S.-listed shares in Novartis AG ADR (NYSE:NVS) climbed on Tuesday after the Swiss drugmaker confirmed its group guidance for 2022 core...